Adenosine A1-A2A Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects

Cells. 2019 Dec 13;8(12):1630. doi: 10.3390/cells8121630.

Abstract

Guanosine, a guanine-based purine nucleoside, has been described as a neuromodulator that exerts neuroprotective effects in animal and cellular ischemia models. However, guanosine's exact mechanism of action and molecular targets have not yet been identified. Here, we aimed to elucidate a role of adenosine receptors (ARs) in mediating guanosine effects. We investigated the neuroprotective effects of guanosine in hippocampal slices from A2AR-deficient mice (A2AR-/-) subjected to oxygen/glucose deprivation (OGD). Next, we assessed guanosine binding at ARs taking advantage of a fluorescent-selective A2AR antagonist (MRS7396) which could engage in a bioluminescence resonance energy transfer (BRET) process with NanoLuc-tagged A2AR. Next, we evaluated functional AR activation by determining cAMP and calcium accumulation. Finally, we assessed the impact of A1R and A2AR co-expression in guanosine-mediated impedance responses in living cells. Guanosine prevented the reduction of cellular viability and increased reactive oxygen species generation induced by OGD in hippocampal slices from wild-type, but not from A2AR-/- mice. Notably, while guanosine was not able to modify MRS7396 binding to A2AR-expressing cells, a partial blockade was observed in cells co-expressing A1R and A2AR. The relevance of the A1R and A2AR interaction in guanosine effects was further substantiated by means of functional assays (i.e., cAMP and calcium determinations), since guanosine only blocked A2AR agonist-mediated effects in doubly expressing A1R and A2AR cells. Interestingly, while guanosine did not affect A1R/A2AR heteromer formation, it reduced A2AR agonist-mediated cell impedance responses. Our results indicate that guanosine-induced effects may require both A1R and A2AR co-expression, thus identifying a molecular substrate that may allow fine tuning of guanosine-mediated responses.

Keywords: A1R/A2AR heteromer; NanoBRET; guanosine; neuroprotection; oxygen/glucose deprivation.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine A2 Receptor Agonists / pharmacology
  • Animals
  • Cell Survival / drug effects
  • Cyclic AMP / genetics
  • Cyclic AMP / metabolism*
  • Female
  • Guanosine / pharmacology*
  • HEK293 Cells
  • Hippocampus / metabolism*
  • Humans
  • Male
  • Mice
  • Mice, Mutant Strains
  • Plasmids
  • Protein Binding / drug effects
  • Reactive Oxygen Species / metabolism
  • Receptor, Adenosine A1 / metabolism*
  • Receptor, Adenosine A2A / metabolism*

Substances

  • Adenosine A2 Receptor Agonists
  • Reactive Oxygen Species
  • Receptor, Adenosine A1
  • Receptor, Adenosine A2A
  • Guanosine
  • Cyclic AMP